… the prediction of the final piperacillin and tazobactam PK models. … piperacillin/tazobactam
every 8 or 12 h evaluated in this study achieved the pharmacodynamic target (free piperacillin …

… observed alterations of pharmacokinetic (PK) parameters, leading to a reduction in β-lactam
concentrations. This study aimed to develop a PK population model for piperacillin in order …

… (CI) piperacillin/tazobactam is frequently used to treat infections in very elderly patients.
This study aimed to conduct a population pharmacokinetic analysis of CI piperacillin/tazobactam, …

… Piperacillin is a broad-spectrum β-lactam antibiotic commonly prescribed in intensive care
units. Many piperacillin population pharmacokinetic models have been published, but few …

… a population pharmacokinetic analysis to evaluate the factors (eg, age, renal function,
frailty) that may impact the disposition of piperacillin/tazobactam across the adult lifespan. …

… The present study describes the population pharmacokinetics of piperacillin targeted at non-…
pharmacokinetics of piperacillin. We also observed that an extended infusion of piperacillin …

… Objective: To describe the population pharmacokinetics (PKs) of piperacillin/tazobactam in
… prospective population PK study was conducted in adult ICU patients prescribed piperacillin/…

… in our population, as shown by a low median pediatric logistic organ dysfunction (PELOD)
score, despite enrollment in the PICU. Our population estimates for piperacillin V c and V p …

… included in our population pharmacokinetic analysis were … There was no difference in the
pharmacokinetic indices for these … These pharmacokinetic data for the piperacillin component …